Response to Letters regarding "Re-infection with SARS-CoV-2 in solid-organ transplant (SOT) recipients: Incidence density and convalescent immunity prior to re-infection" [0.03%]
对“关于‘器官移植受者再次感染SARS-CoV-2：再感染前的累积恢复期免疫力和发病率’”来信的回复
Stephen Morris,Giselle Guerra,Yoichiro Natori
Stephen Morris
Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center [0.03%]
免疫抑制剂诱导的巨细胞病毒感染及其危险因素分析
Emily Viehl,Alicia Lichvar,Christine Chan et al.
Emily Viehl et al.
Background: Cytomegalovirus (CMV) is a common opportunistic infection in patients after liver transplant (LT). Guidelines recommend 900 mg daily of valganciclovir; however, valganciclovir commonly causes dose-dependent he...
Cytomegalovirus antiviral stewardship in solid organ transplant recipients: A new gold standard [0.03%]
实体器官移植受者巨细胞病毒抗病毒药物管理：新标准？
Margaret R Jorgenson,Jillian L Descourouez,Hanna Kleiboeker et al.
Margaret R Jorgenson et al.
Purpose: Antimicrobial stewardship programs (ASPs) are essential entities that promote the appropriate use of antimicrobials, leading to improved patient outcomes and reduced resistance. Application to the immunocompromis...
Maribavir does not significantly influence tacrolimus dose requirements in solid organ transplant recipients [0.03%]
马博维林不影响实体器官移植受者的他克莫司剂量需求
David C Sabatino,Jessica Hedvat,David M Salerno et al.
David C Sabatino et al.
Economic and clinical burden associated with respiratory viral infections after allogeneic hematopoietic cell transplant in the United States [0.03%]
美国异基因造血细胞移植后呼吸道病毒感染的相关经济和临床负担
Michael G Ison,Francisco M Marty,Nelson Chao et al.
Michael G Ison et al.
Background: Allogeneic hematopoietic cell transplant (allo-HCT) recipients are at increased risk for respiratory viral infections (RVIs), which invoke substantial morbidity and mortality. Limited effective antiviral optio...
Comparison of short-course antibiotic therapy of 6 or less days with a longer treatment in patients with cholangitis after liver transplantation [0.03%]
短于6天与较长抗生素治疗在肝移植后胆管炎患者中的比较研究
Philip G Ferstl,Alexander Queck,Katharina Bremer et al.
Philip G Ferstl et al.
Objectives: Stenosis of the biliary anastomosis predisposes liver graft recipients to bacterial cholangitis. Antibiotic therapy (AT) is performed according to individual clinical judgment, but duration of AT remains uncle...
Immune reconstitution inflammatory syndrome in a non-HIV immunocompromised patient with Pneumocystis Jirovecii pneumonia [0.03%]
非艾滋病免疫缺陷患者卡氏肺孢子虫肺炎并发免疫重建炎症综合征
Rueda Prada Libardo,Raymund R Razonable
Rueda Prada Libardo
Infectious complications in acute graft-versus-host disease after liver transplantation [0.03%]
急性肝移植后移植物抗宿主病的感染并发症
Supavit Chesdachai,Prowpanga Udompap,Zachary A Yetmar et al.
Supavit Chesdachai et al.
Graft-versus-hostdisease (GVHD) following liver transplantation (LT) is rare but can lead tosignificant mortality. The leading cause of death following GVHD diagnosis isinfectious complications. However, there is a lack of clear description...
Hepatitis A transmission to two kidney transplant recipients from a shared donor [0.03%]
一起肝移植病例的甲型肝炎病毒感染事件
Hope E Werenski,Colleen L Jay,Ryan C Maves
Hope E Werenski
Lisa Kriegl,Johannes Boyer,Matthias Egger et al.
Lisa Kriegl et al.
Background: Antifungal stewardship (AFS) has emerged as an important component of quality in managing invasive fungal infections (IFIs), and cost-benefit calculations suggest regular training in AFS is well worth the effo...